ORIENT BIO Inc. (002630.KS) KSC

Currency In KRW

AD

Valuation

Market Cap68.54B
Enterprise Value64.65B
P/E Ratio-485.64
PEG Ratio-2.55
Price/Sales Ratio1.89
Price/Book Ratio1.5
Enterprise/Revenue1.55
Enterprise/EBITDA8.22

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.03

Income Statement

Revenue29.75B
Revenue/Share241.74
Gross Profit3.96B
EBITDA-2.24B
Net Income-4.57B
Diluted EPS-77.03

Balance Sheet

Total Cash38.08B
Total Cash/Share321.12
Total Debt1.19B
Total Debt/Equity0.02
Current Ratio14.09
Book Value Per Share609.45

Price History

52-Week Change-27.54
52-Week High1,632
52-Week Low745
Moving Average 50 Days923.28
Moving Average 200 Days1,068.72

Statistics

Average Volume401,221
Shares Outstanding59.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:2
Last Split DateJune 09, 2026
AD